+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Recombinant Human Bone Morphogenetic Protein 2 Market - Global Forecast 2025-2030- Product Image
Recombinant Human Bone Morphogenetic Protein 2 Market - Global Forecast 2025-2030- Product Image
Sale

Recombinant Human Bone Morphogenetic Protein 2 Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 181 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6138477
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Senior executives seeking to optimize outcomes and operational resilience in regenerative medicine and surgical reconstruction will benefit from actionable insights provided on the recombinant human bone morphogenetic protein 2 (recombinant BMP-2) market. This report presents strategic intelligence across clinical, technological, and supply-chain dimensions driving adoption in an evolving global environment.

Market Snapshot: Recombinant Human Bone Morphogenetic Protein 2 Landscape

The global recombinant BMP-2 market demonstrates sustained growth, propelled by its expanding use in spinal fusion, orthopedic repair, oral-maxillofacial procedures, and advanced delivery platforms. Adoption by leading hospitals and specialty clinics is increasing, supported by improved regulatory clarity and innovations in minimally invasive techniques. Strategic partnerships between biotech, device manufacturers, and supply chain stakeholders further strengthen market momentum and facilitate diverse clinical applications. Additionally, recent tariff implementations have created a landscape where both domestic production and advanced manufacturing processes play a pivotal role in cost management and continual access.

Scope & Segmentation

This report offers analytical coverage across the full recombinant BMP-2 value chain. The study provides a detailed view of market segmentation to assist decision-makers in evaluating opportunities and risk.

  • Application Areas: Dental augmentation, long bone repair, maxillofacial surgery, and spinal fusion (including both interbody and posterolateral approaches).
  • End Users: Hospitals (teaching and non-teaching), ambulatory surgical centers, and specialty clinics.
  • Formulation Types: Collagen sponges, gels, and injectable formulations, enabling diverse procedural techniques and deployment settings.
  • Distribution Channels: Direct sales, hospital pharmacies, online channels, and retail pharmacies ensure broad and timely distribution.
  • Regional Coverage: Americas (US, Canada, Mexico, Brazil, Argentina), Europe, Middle East, and Africa (UK, Germany, France, Russia, and additional countries), and Asia-Pacific (China, Japan, India, Australia, Korea, Southeast Asia, and others).
  • Industry Innovators: Leading and emerging companies like Medtronic plc, Stryker Corporation, Zimmer Biomet Holdings, Johnson & Johnson, Arthrex, Orthofix Medical, Globus Medical, Baxter International, RTI Surgical Holdings, and Collagen Matrix.

Key Takeaways

  • Clinical deployment of recombinant BMP-2 has expanded beyond traditional use cases, empowering physicians to address complex bone regeneration needs with reduced procedural morbidity.
  • Technological advancements in carrier matrices, including hydrogels and nanofiber scaffolds, deliver greater control over protein release and enhance surgical adaptability for varied anatomical sites.
  • Strategic alliances and mergers are driving a more collaborative and agile ecosystem, enabling faster commercialization and broader market reach for next-generation formulations.
  • Regulatory shifts have refined post-market surveillance, supporting the safe integration of BMP-2 into minimally invasive and digitally guided procedural workflows.
  • Supply chain adaptation—prompted by tariff impacts and cost variability—has led manufacturers to diversify sourcing models and invest in regional manufacturing capabilities for increased resilience.

Tariff Impact on Supply and Innovation

Tariffs enacted in 2025 on recombinant biologics significantly affected the recombinant BMP-2 market. Elevated import costs prompted healthcare providers to consider domestic sources, spurring investments in local biomanufacturing and encouraging strategic partnerships. Manufacturers are optimizing sourcing strategies, renegotiating supplier contracts, and exploring innovative expression systems and carrier technologies to offset costs. These adjustments have intensified focus on supply chain agility and operational flexibility, fueling collaborative innovation and supporting continuity in clinical deployment despite external pressures.

Methodology & Data Sources

This analysis synthesizes primary interviews with clinical leaders, R&D teams, and supply chain managers across the value chain. Findings are triangulated with secondary research from peer-reviewed literature, regulatory filings, and health authority data. Patent reviews and expert advisory input enhance transparency, minimize bias, and ensure actionable conclusions across dynamic policy and market conditions.

Why This Report Matters

  • Enables senior leaders to anticipate clinical, technological, and policy trends for recombinant BMP-2 solutions in a changing international market.
  • Offers tools for strategic planning, risk management, and resource allocation by mapping segment-specific drivers and competitive landscapes.
  • Supports informed investment in innovation, manufacturing, and partnership formation aligned with evolving clinical adoption models.

Conclusion

Recombinant BMP-2 is positioned as a transformative technology within regenerative medicine and surgical reconstruction. Navigating its market requires strategic foresight, operational agility, and collaborative innovation to deliver sustainable growth and improved patient outcomes.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Surge in demand for rhBMP-2 in spinal fusion procedures among aging populations
5.2. Emergence of biosimilar rhBMP-2 candidates challenging market leaders on cost and efficacy
5.3. Integration of advanced biomaterial carriers to optimize sustained rhBMP-2 delivery and safety
5.4. Adoption of 3D printed scaffold platforms combined with rhBMP-2 for personalized bone reconstruction
5.5. Growing regulatory approvals for novel rhBMP-2 formulations in key emerging healthcare markets
5.6. Strategic partnerships between biotech firms and device manufacturers for next generation rhBMP-2 implants
5.7. Clinical trial results demonstrating improved fracture healing with combination therapies of rhBMP-2
5.8. Advances in sustained release rhBMP-2 hydrogel formulations reducing adverse inflammatory responses
5.9. Increasing use of point of care rhBMP-2 application kits in outpatient orthopedic surgical centers for efficiency
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Recombinant Human Bone Morphogenetic Protein 2 Market, by Application
8.1. Introduction
8.2. Dental Augmentation
8.3. Long Bone Repair
8.4. Maxillofacial Surgery
8.5. Spinal Fusion
8.5.1. Interbody Fusion
8.5.2. Posterolateral Fusion
9. Recombinant Human Bone Morphogenetic Protein 2 Market, by End User
9.1. Introduction
9.2. Ambulatory Surgical Centers
9.3. Hospitals
9.3.1. Non Teaching Hospitals
9.3.2. Teaching Hospitals
9.4. Specialty Clinics
10. Recombinant Human Bone Morphogenetic Protein 2 Market, by Formulation
10.1. Introduction
10.2. Collagen Sponge
10.3. Gel
10.4. Injectable
11. Recombinant Human Bone Morphogenetic Protein 2 Market, by Distribution Channel
11.1. Introduction
11.2. Direct Sales
11.3. Hospital Pharmacy
11.4. Online Pharmacy
11.5. Retail Pharmacy
12. Americas Recombinant Human Bone Morphogenetic Protein 2 Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Recombinant Human Bone Morphogenetic Protein 2 Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Recombinant Human Bone Morphogenetic Protein 2 Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Medtronic plc
15.3.2. Stryker Corporation
15.3.3. Zimmer Biomet Holdings, Inc.
15.3.4. Johnson & Johnson
15.3.5. Arthrex, Inc.
15.3.6. Orthofix Medical Inc.
15.3.7. Globus Medical, Inc.
15.3.8. Baxter International Inc.
15.3.9. RTI Surgical Holdings, Inc.
15.3.10. Collagen Matrix, LLC
16. Research AI17. Research Statistics18. Research Contacts19. Research Articles20. Appendix
List of Figures
FIGURE 1. RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 6. GLOBAL RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 8. GLOBAL RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY FORMULATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY FORMULATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET: RESEARCHAI
FIGURE 24. RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET: RESEARCHSTATISTICS
FIGURE 25. RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET: RESEARCHCONTACTS
FIGURE 26. RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY DENTAL AUGMENTATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY DENTAL AUGMENTATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY LONG BONE REPAIR, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY LONG BONE REPAIR, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY MAXILLOFACIAL SURGERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY MAXILLOFACIAL SURGERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY SPINAL FUSION, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY SPINAL FUSION, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY INTERBODY FUSION, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY INTERBODY FUSION, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY POSTEROLATERAL FUSION, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY POSTEROLATERAL FUSION, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY SPINAL FUSION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY SPINAL FUSION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY NON TEACHING HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY NON TEACHING HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY TEACHING HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY TEACHING HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY COLLAGEN SPONGE, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY COLLAGEN SPONGE, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY GEL, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY GEL, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY INJECTABLE, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. AMERICAS RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 58. AMERICAS RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 59. AMERICAS RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY SPINAL FUSION, 2018-2024 (USD MILLION)
TABLE 60. AMERICAS RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY SPINAL FUSION, 2025-2030 (USD MILLION)
TABLE 61. AMERICAS RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 62. AMERICAS RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 63. AMERICAS RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 64. AMERICAS RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 65. AMERICAS RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 66. AMERICAS RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 67. AMERICAS RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 68. AMERICAS RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 69. AMERICAS RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 70. AMERICAS RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 71. UNITED STATES RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 72. UNITED STATES RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 73. UNITED STATES RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY SPINAL FUSION, 2018-2024 (USD MILLION)
TABLE 74. UNITED STATES RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY SPINAL FUSION, 2025-2030 (USD MILLION)
TABLE 75. UNITED STATES RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 76. UNITED STATES RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 77. UNITED STATES RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 78. UNITED STATES RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 79. UNITED STATES RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 80. UNITED STATES RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 81. UNITED STATES RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 82. UNITED STATES RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 83. UNITED STATES RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 84. UNITED STATES RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 85. CANADA RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 86. CANADA RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 87. CANADA RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY SPINAL FUSION, 2018-2024 (USD MILLION)
TABLE 88. CANADA RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY SPINAL FUSION, 2025-2030 (USD MILLION)
TABLE 89. CANADA RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 90. CANADA RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 91. CANADA RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 92. CANADA RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 93. CANADA RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 94. CANADA RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 95. CANADA RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 96. CANADA RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 97. MEXICO RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 98. MEXICO RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 99. MEXICO RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY SPINAL FUSION, 2018-2024 (USD MILLION)
TABLE 100. MEXICO RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY SPINAL FUSION, 2025-2030 (USD MILLION)
TABLE 101. MEXICO RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 102. MEXICO RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 103. MEXICO RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 104. MEXICO RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 105. MEXICO RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 106. MEXICO RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 107. MEXICO RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 108. MEXICO RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 109. BRAZIL RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 110. BRAZIL RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 111. BRAZIL RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY SPINAL FUSION, 2018-2024 (USD MILLION)
TABLE 112. BRAZIL RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY SPINAL FUSION, 2025-2030 (USD MILLION)
TABLE 113. BRAZIL RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 114. BRAZIL RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 115. BRAZIL RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 116. BRAZIL RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 117. BRAZIL RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 118. BRAZIL RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 119. BRAZIL RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 120. BRAZIL RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 121. ARGENTINA RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 122. ARGENTINA RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 123. ARGENTINA RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY SPINAL FUSION, 2018-2024 (USD MILLION)
TABLE 124. ARGENTINA RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY SPINAL FUSION, 2025-2030 (USD MILLION)
TABLE 125. ARGENTINA RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 126. ARGENTINA RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 127. ARGENTINA RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 128. ARGENTINA RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 129. ARGENTINA RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 130. ARGENTINA RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 131. ARGENTINA RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 132. ARGENTINA RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 133. EUROPE, MIDDLE EAST & AFRICA RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 134. EUROPE, MIDDLE EAST & AFRICA RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 135. EUROPE, MIDDLE EAST & AFRICA RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY SPINAL FUSION, 2018-2024 (USD MILLION)
TABLE 136. EUROPE, MIDDLE EAST & AFRICA RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY SPINAL FUSION, 2025-2030 (USD MILLION)
TABLE 137. EUROPE, MIDDLE EAST & AFRICA RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 138. EUROPE, MIDDLE EAST & AFRICA RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 139. EUROPE, MIDDLE EAST & AFRICA RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 140. EUROPE, MIDDLE EAST & AFRICA RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 141. EUROPE, MIDDLE EAST & AFRICA RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 142. EUROPE, MIDDLE EAST & AFRICA RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 143. EUROPE, MIDDLE EAST & AFRICA RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 144. EUROPE, MIDDLE EAST & AFRICA RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 145. EUROPE, MIDDLE EAST & AFRICA RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 146. EUROPE, MIDDLE EAST & AFRICA RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 147. UNITED KINGDOM RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 148. UNITED KINGDOM RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 149. UNITED KINGDOM RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY SPINAL FUSION, 2018-2024 (USD MILLION)
TABLE 150. UNITED KINGDOM RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY SPINAL FUSION, 2025-2030 (USD MILLION)
TABLE 151. UNITED KINGDOM RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 152. UNITED KINGDOM RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 153. UNITED KINGDOM RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 154. UNITED KINGDOM RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 155. UNITED KINGDOM RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 156. UNITED KINGDOM RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 157. UNITED KINGDOM RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 158. UNITED KINGDOM RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 159. GERMANY RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 160. GERMANY RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 161. GERMANY RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY SPINAL FUSION, 2018-2024 (USD MILLION)
TABLE 162. GERMANY RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY SPINAL FUSION, 2025-2030 (USD MILLION)
TABLE 163. GERMANY RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 164. GERMANY RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 165. GERMANY RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 166. GERMANY RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 167. GERMANY RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 168. GERMANY RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 169. GERMANY RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 170. GERMANY RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 171. FRANCE RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 172. FRANCE RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 173. FRANCE RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY SPINAL FUSION, 2018-2024 (USD MILLION)
TABLE 174. FRANCE RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY SPINAL FUSION, 2025-2030 (USD MILLION)
TABLE 175. FRANCE RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 176. FRANCE RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 177. FRANCE RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 178. FRANCE RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 179. FRANCE RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 180. FRANCE RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 181. FRANCE RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 182. FRANCE RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 183. RUSSIA RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 184. RUSSIA RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 185. RUSSIA RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY SPINAL FUSION, 2018-2024 (USD MILLION)
TABLE 186. RUSSIA RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY SPINAL FUSION, 2025-2030 (USD MILLION)
TABLE 187. RUSSIA RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 188. RUSSIA RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 189. RUSSIA RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 190. RUSSIA RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 191. RUSSIA RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 192. RUSSIA RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 193. RUSSIA RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 194. RUSSIA RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 195. ITALY RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 196. ITALY RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 197. ITALY RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY SPINAL FUSION, 2018-2024 (USD MILLION)
TABLE 198. ITALY RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY SPINAL FUSION, 2025-2030 (USD MILLION)
TABLE 199. ITALY RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 200. ITALY RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 201. ITALY RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 202. ITALY RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 203. ITALY RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 204. ITALY RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 205. ITALY RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 206. ITALY RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 207. SPAIN RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 208. SPAIN RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 209. SPAIN RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY SPINAL FUSION, 2018-2024 (USD MILLION)
TABLE 210. SPAIN RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY SPINAL FUSION, 2025-2030 (USD MILLION)
TABLE 211. SPAIN RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 212. SPAIN RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 213. SPAIN RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 214. SPAIN RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 215. SPAIN RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 216. SPAIN RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 217. SPAIN RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 218. SPAIN RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 219. UNITED ARAB EMIRATES RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 220. UNITED ARAB EMIRATES RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 221. UNITED ARAB EMIRATES RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY SPINAL FUSION, 2018-2024 (USD MILLION)
TABLE 222. UNITED ARAB EMIRATES RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY SPINAL FUSION, 2025-2030 (USD MILLION)
TABLE 223. UNITED ARAB EMIRATES RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 224. UNITED ARAB EMIRATES RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 225. UNITED ARAB EMIRATES RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 226. UNITED ARAB EMIRATES RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 227. UNITED ARAB EMIRATES RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 228. UNITED ARAB EMIRATES RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 229. UNITED ARAB EMIRATES RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 230. UNITED ARAB EMIRATES RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 231. SAUDI ARABIA RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 232. SAUDI ARABIA RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 233. SAUDI ARABIA RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY SPINAL FUSION, 2018-2024 (USD MILLION)
TABLE 234. SAUDI ARABIA RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY SPINAL FUSION, 2025-2030 (USD MILLION)
TABLE 235. SAUDI ARABIA RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 236. SAUDI ARABIA RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 237. SAUDI ARABIA RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 238. SAUDI ARABIA RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 239. SAUDI ARABIA RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 240. SAUDI ARABIA RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 241. SAUDI ARABIA RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 242. SAUDI ARABIA RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 243. SOUTH AFRICA RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 244. SOUTH AFRICA RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 245. SOUTH AFRICA RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY SPINAL FUSION, 2018-2024 (USD MILLION)
TABLE 246. SOUTH AFRICA RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY SPINAL FUSION, 2025-2030 (USD MILLION)
TABLE 247. SOUTH AFRICA RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 248. SOUTH AFRICA RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 249. SOUTH AFRICA RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 250. SOUTH AFRICA RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 251. SOUTH AFRICA RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 252. SOUTH AFRICA RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 253. SOUTH AFRICA RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 254. SOUTH AFRICA RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 255. DENMARK RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 256. DENMARK RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 257. DENMARK RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY SPINAL FUSION, 2018-2024 (USD MILLION)
TABLE 258. DENMARK RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY SPINAL FUSION, 2025-2030 (USD MILLION)
TABLE 259. DENMARK RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 260. DENMARK RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 261. DENMARK RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 262. DENMARK RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 263. DENMARK RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 264. DENMARK RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 265. DENMARK RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 266. DENMARK RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Recombinant Human Bone Morphogenetic Protein 2 Market report include:
  • Medtronic plc
  • Stryker Corporation
  • Zimmer Biomet Holdings, Inc.
  • Johnson & Johnson
  • Arthrex, Inc.
  • Orthofix Medical Inc.
  • Globus Medical, Inc.
  • Baxter International Inc.
  • RTI Surgical Holdings, Inc.
  • Collagen Matrix, LLC

Related Topics

Related Reports

Bone Morphogenetic Proteins - Global Strategic Business Report - Product Image

Bone Morphogenetic Proteins - Global Strategic Business Report

  • Report
  • 202 Pages
  • Global
From
Bone Morphogenetic Protein Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Bone Morphogenetic Protein Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 185 Pages
  • Global
From
Human Bone Morphogenetic Protein-9 Kit Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Human Bone Morphogenetic Protein-9 Kit Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
Bone Morphogenetic Protein Market - Global Forecast 2025-2032 - Product Image

Bone Morphogenetic Protein Market - Global Forecast 2025-2032

  • Report
  • 195 Pages
  • Global
From
Bone Morphogenetic Protein Market Size, Share & Trends Analysis Report by Type (rhBMP-2, rhBMP-7), Application (Spinal Fusion, Trauma, Reconstruction, Oral Maxillofacial), Region, and Segment Forecasts, 2025-2030 - Product Image

Bone Morphogenetic Protein Market Size, Share & Trends Analysis Report by Type (rhBMP-2, rhBMP-7), Application (Spinal Fusion, Trauma, Reconstruction, Oral Maxillofacial), Region, and Segment Forecasts, 2025-2030

  • Report
  • 120 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.